- Home
- CSW vs ACLX Comparison
CSW vs ACLX Comparison
Compare CSW & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSW
- ACLX
- Stock Information
- Founded
- CSW 2014
- ACLX 2015
- Country
- CSW United States
- ACLX United States
- Employees
- CSW N/A
- ACLX N/A
- Industry
- CSW Home Furnishings
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- CSW Industrials
- ACLX Health Care
- Exchange
- CSW Nasdaq
- ACLX Nasdaq
- Market Cap
- CSW 4.4B
- ACLX 4.1B
- IPO Year
- CSW N/A
- ACLX 2022
- Fundamental
- Price
- CSW $272.81
- ACLX $71.28
- Analyst Decision
- CSW Hold
- ACLX Strong Buy
- Analyst Count
- CSW 3
- ACLX 14
- Target Price
- CSW $292.67
- ACLX $114.75
- AVG Volume (30 Days)
- CSW 193.3K
- ACLX 522.3K
- Earning Date
- CSW 07-31-2025
- ACLX 08-07-2025
- Dividend Yield
- CSW 0.40%
- ACLX N/A
- EPS Growth
- CSW 19.18
- ACLX N/A
- EPS
- CSW 8.37
- ACLX N/A
- Revenue
- CSW $915,770,000.00
- ACLX $56,979,000.00
- Revenue This Year
- CSW $22.51
- ACLX N/A
- Revenue Next Year
- CSW $8.46
- ACLX $108.81
- P/E Ratio
- CSW $32.66
- ACLX N/A
- Revenue Growth
- CSW 12.27
- ACLX N/A
- 52 Week Low
- CSW $242.00
- ACLX $47.86
- 52 Week High
- CSW $436.50
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- CSW 51.51
- ACLX 52.20
- Support Level
- CSW $256.79
- ACLX $69.00
- Resistance Level
- CSW $269.67
- ACLX $74.74
- Average True Range (ATR)
- CSW 9.59
- ACLX 3.47
- MACD
- CSW 1.37
- ACLX -0.19
- Stochastic Oscillator
- CSW 66.58
- ACLX 56.94
About CSW CSW Industrials Inc. Common Stock
CSW Industrials Inc is a diversified industrial growth company with well-established, scalable platforms and domain expertise across three segments, Contractor Solutions, Engineered Building Solutions, and Specialized Reliability Solutions. The company's Contractor Solutions segment involves manufacturing efficient and performance-enhancing products for residential and commercial HVAC/R and plumbing applications, which are designed for professional end-use customers. Majority of the company revenue is generated from Contractor Solutions segment from U.S. markets.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.